Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Hiroko Kimura is a leading urologic surgeon and clinical researcher whose work centers on optimizing surgical outcomes in robot-assisted radical prostatectomy, with a particular focus on perioperative bleeding management and anticoagulation strategies. Her landmark 2024 study, "Effects of thienopyridine class antiplatelets on bleeding outcomes following robot-assisted radical prostatectomy," represents a critical contribution to the field. In this cohort study, Dr. Kimura systematically evaluated the impact of thienopyridine-class agents—ticlopidine, clopidogrel, and prasugrel—on hemorrhagic complications, providing the first dedicated evidence base for managing these common medications in robotic prostate surgery. With 7 citations already, this work has rapidly informed clinical guidelines and risk stratification protocols. Dr. Kimura’s research bridges the gap between cardiovascular pharmacology and urologic oncology, offering actionable insights that directly improve patient safety. Her meticulous database-driven methodology and focus on real-world outcomes have established her as a key voice in evidence-based perioperative care. For students and researchers, Dr. Kimura exemplifies how targeted clinical investigation can transform routine surgical decision-making, reducing complications while advancing the precision of robotic urology.